FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to methods of treatment of multiple myeloma. The method includes high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AutoHSCT). Rexod is administered by intravenous drip three days before the start of chemotherapy at a dosage of 9.6 million units, as well as on the first, seventh and fourteenth days after AutoHSCT at a dosage of 12.8 million units. Additionally, Rexod is administered on the twenty-first day after AutoHSCT in a single dose of 9.6 million units.
EFFECT: method provides reducing the frequency and severity of toxic and infectious complications associated with high-dose chemotherapy and subsequent autoHSCT, due to the introduction of Rexod.
2 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TRANSPLANTATION OF PERIPHERAL BLOOD AUTOLOGOUS HAEMOPOIETIC STEM CELLS | 2019 |
|
RU2734121C1 |
| METHOD FOR CORRECTION OF AMEGAKARYOCYTIC THROMBOCYTOPENIA | 2012 |
|
RU2519745C2 |
| POEMS-SYNDROME DIAGNOSTIC METHOD | 2015 |
|
RU2605284C2 |
| METHOD FOR PREDICTING EFFECTIVE MOBILISATION OF HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA | 2020 |
|
RU2757964C1 |
| METHOD FOR DETECTION OF PRIMARY REFRACTORY FORM OF MULTIPLE MYELOMA AT THE DISEASE ONSET | 2020 |
|
RU2749612C1 |
| METHOD FOR TREATMENT OF LOWER LIMBS ISCHEMIC DISEASES | 2015 |
|
RU2633487C2 |
| METHOD OF STORAGE OF NON-CRYOPRESERVED AUTOLOGOUS HEMATOPOIETIC STEM CELLS FROM PERIPHERAL BLOOD | 2022 |
|
RU2799019C1 |
| METHOD OF POLYCHEMOTHERAPEUTIC ENTEROPATHY PREVENTION AND TREATMENT | 2009 |
|
RU2405546C1 |
| METHOD FOR MORPHOMETRIC ESTIMATION OF PREDICTION OF CLINICAL COURSE OF NODULAR SCLEROSIS OF HODGKIN LYMPHOMA BY A PERCENTAGE SCORE CD163+ AND CD68+ MACROPHAGES IN LYMPH NODES | 2020 |
|
RU2738863C1 |
| METHOD OF TREATING EPILEPSY | 2013 |
|
RU2538724C1 |
